|
TRPM7 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.5949000009563E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.50289830264705E-11 |
| Normal-vs-Stage2 |
1.6698999960596E-08 |
| Normal-vs-Stage3 |
7.279800E-01 |
| Normal-vs-Stage4 |
7.51469999999976E-05 |
| Stage1-vs-Stage2 |
8.707600E-01 |
| Stage1-vs-Stage3 |
1.039800E-01 |
| Stage1-vs-Stage4 |
8.664600E-01 |
| Stage2-vs-Stage3 |
9.891700E-02 |
| Stage2-vs-Stage4 |
7.210800E-01 |
| Stage3-vs-Stage4 |
1.295650E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.3270499950363E-12 |
| Normal-vs-AfricanAmerican |
2.107600E-02 |
| Normal-vs-Asian |
4.786400E-01 |
| Caucasian-vs-AfricanAmerican |
1.714590E-01 |
| Caucasian-vs-Asian |
3.010400E-01 |
| AfricanAmerican-vs-Asian |
3.591600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.24560370298832E-11 |
| Normal-vs-Female |
1.879000E-01 |
| Male-vs-Female |
5.827800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.528460E-02 |
| Normal-vs-Extreme_Weight |
1.62436730732907E-12 |
| Normal-vs-Obese |
9.178600E-03 |
| Normal-vs-Extreme_Obese |
5.000600E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.463000E-01 |
| Normal_Weight-vs-Obese |
7.997600E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.696200E-01 |
| Extreme_Weight-vs-Obese |
2.944400E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.108800E-01 |
| Obese-vs-Extreme_Obese |
7.537200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.389400E-01 |
| Normal-vs-Age(41-60Yrs) |
5.417700E-04 |
| Normal-vs-Age(61-80Yrs) |
1.78101977610368E-12 |
| Normal-vs-Age(81-100Yrs) |
1.45370000037559E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.110000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.286200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.031800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.979920E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.522000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.244800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.87694304543129E-12 |
| Normal-VS-Type2 PRCC |
1.696760E-01 |
| Normal-VS-KIRP CIMP |
1.65267999999719E-05 |
| Normal-VS-Unclassified PRCC |
2.644500E-03 |
| Type1 PRCC-VS-Type2 PRCC |
9.068200E-02 |
| Type1 PRCC-VS-KIRP CIMP |
9.094800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.780200E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.343630E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.590600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.353200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.089540E-02 |
| Normal-vs-N1 |
8.948200E-01 |
| Normal-vs-N2 |
2.06640000000036E-06 |
| N0-vs-N1 |
3.456600E-01 |
| N0-vs-N2 |
1.339870E-03 |
| N1-vs-N2 |
4.038000E-02 |
|
|
